Cargando…
Potent Sensitisation of Cancer Cells to Anticancer Drugs by a Quadruple Mutant of the Human Deoxycytidine Kinase
Identifying enzymes that, once introduced in cancer cells, lead to an increased efficiency of treatment constitutes an important goal for biomedical applications. Using an original procedure whereby mutant genes are generated based on the use of conditional lentivector genome mobilisation, we recent...
Autores principales: | Coulibaly, Safiatou T., Rossolillo, Paola, Winter, Flore, Kretzschmar, Franziska K., Brayé, Mélanie, Martin, Darren P., Lener, Daniela, Negroni, Matteo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4618062/ https://www.ncbi.nlm.nih.gov/pubmed/26485161 http://dx.doi.org/10.1371/journal.pone.0140741 |
Ejemplares similares
-
Retrovolution: HIV–Driven Evolution of Cellular Genes and Improvement of Anticancer Drug Activation
por: Rossolillo, Paola, et al.
Publicado: (2012) -
A snapshot on HIV-1 evolution through the identification of phylogenetic-specific properties of HIV-1 integrases M/O
por: Toccafondi, Elenia, et al.
Publicado: (2023) -
Anticancer efficacy of cisplatin and trichostatin A or 5-aza-2′-deoxycytidine on ovarian cancer
por: Meng, F, et al.
Publicado: (2013) -
The external domains of the HIV-1 envelope are a mutational cold spot
por: Geller, Ron, et al.
Publicado: (2015) -
Deletion Mutants of Human Deoxycytidine Kinase mRNA in Cells Resistant to Antitumor Cytosine Nucleosides
por: Obata, Tohru, et al.
Publicado: (2001)